Green Molecular
unknown
unknown
Stage
1
Investors
About
Develops pterostilbene-based formulations intended for dermatology and oncology applications.
Explore Green Molecular's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.